Wednesday, 22 Jan 2020

You are here

Neuropathic Like Knee Pain

Fernandez and colleagues have shed further light on a significant subset of patients with knee pain - specifically, those with neuropathic like knee pain (NKP) that includes those with knee pain modified by central and peripheral neurologic dysfunction.

They undertook a cross-sectional study of a UK (n = 9506) postal questionnaire. Questions included KP severity (numerical rating scale) identifying those with knee pain (KP).

They found that KP was common (28.2%) amongst responders, and that nearly half of these (13.65%) qualified as NKP (i.e., 3.9% of the total population). 

NKP was based on the modified painDETECT questionnaire (PDQ) and implies either central or localised damage to the nervous system or nerve fibres around that modifies the KP experience. NKP has symptoms of pain, burning pain, tingling or prickling, mechanical and thermal hyperalgesia, allodynia, paroxysmal pain and numbness.

Those with NKP were more likely to be women and have fibromyalgia (OR=4.07). widespread pain (OR 1.93), nodal osteoarthritis (OR 1.80), injury (OR 1.50), pain catastrophising (OR 5.37) and fatigue (OR 5.37) compared with non-NKP respondents.

Their data suggest that primarily central risk factors contributed to NKP (8% central vs. 3% peripheral contributions).

Identifiying NKP and central risk factors may help modify treatment strategies.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Should We Screen Younger Postmenopausal Women for Osteoporosis?

Do postmenopausal women, under age 65 years, need a baseline BMD testing? A JAMA Insights review suggests that the absolute risk of fracture is low in this group and that USPSTF guidelines should be considered - that we should be screening women younger than 65 years who are at increased risk of osteoporosis and we should be using a formal risk assessment tool to identify candidates for bone density testing.

Genicular Artery Embolization to Treat Osteoarthritis Knee Pain

A study from the Journal of Vascular and Interventional Radiology has shown that  knee pain secondary to osteoarthritis (OA) may be effectively treated by selective vascular interruption (embolization) showing efficacy and safety in a small pilot trial. 

ACR-Arthritis Foundation Treatment Guidelines for Osteoarthritis

Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released the 2019 ACR/AF Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee. The ACR periodically updates guidelines to reflect any advances in management added to the literature since the last publication, which in this case was 2012.

Short-term Benefit with Prednisolone in Hand Osteoarthritis

Lancet reports that prednisolone 10 mg daily for 6 weeks can effectively control the pain of hand osteoarthritis (OA), according to results from the Hand Osteoarthritis Prednisolone Efficacy (HOPE) study. This was a double-blind, randomized, placebo-controlled trial aimed to assess the short-term effects of prednisolone in painful hand OA and synovial inflammation. Patients were required to have hand OA and signs of inflammation in their distal and proximal interphalangeal (DIP/PIP) joints and > 4 DIP/PIP osteoarthritic nodes and at least one DIP/PIP joint with soft swelling/erythema or evidence of synovitis on power Doppler ultrasound. The primary endpoint was finger pain.

Physical Activity Lowers Fracture Risk in Post-Menopausal Women

An analysis from the Women’s Health Initiative study shows that postmenopausal women who participate in vigorous physical activity have a statistically lower risk of total and site-specific fractures